您现在的位置: 首页> 研究主题> KAI1基因

KAI1基因

KAI1基因的相关文献在1998年到2019年内共计92篇,主要集中在肿瘤学、基础医学、细胞生物学 等领域,其中期刊论文88篇、会议论文3篇、专利文献86735篇;相关期刊59种,包括中华胰腺病杂志、中华内科杂志、中华消化杂志等; 相关会议3种,包括中华医学会第十八次全国儿科学术会议、中国抗癌学会肺癌专业委员会第十二届全国肺癌学术大会、第十五届全国临床肿瘤学大会暨2012年CSCO学术年会等;KAI1基因的相关文献由258位作者贡献,包括郭晓钟、刘民培、徐建华等。

KAI1基因—发文量

期刊论文>

论文:88 占比:0.10%

会议论文>

论文:3 占比:0.00%

专利文献>

论文:86735 占比:99.90%

总计:86826篇

KAI1基因—发文趋势图

KAI1基因

-研究学者

  • 郭晓钟
  • 刘民培
  • 徐建华
  • 任丽楠
  • 方伟岗
  • 李珊珊
  • 沈琼
  • 任秀花
  • 李宏宇
  • 田宏
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 李俊军
    • 摘要: 目的 对KAI1基因抑制胰腺癌淋巴转移的作用及其相关机制的进行了研究.方法 皮下注射MIAPaCa-2 、MIAPaCa-2-p、MIAPaCa-2-p-k胰腺癌肿瘤细胞,利用免疫组化方法检测肿瘤组织中淋巴管特异性标志物LYVE-1计算淋巴管密度.结果 MIAPCa-K组淋巴转移显著低于MIAPCa-组和MIAPaCa-p组(P<0.05).结论 KAI1基因能胰腺癌细胞的皮下移植肿瘤的淋巴转移,从而减少了淋巴转移的作用机制,为该基因在临床治疗中的应用提供了新依据.
    • 朱波; 赵惠柳; 王英; 劳明; 黄昭东; 刘志民; 谢娟; 欧超
    • 摘要: 目的:探讨KAI1基因和基质金属蛋白酶抑制剂1(TIMP-1)、基质金属蛋白酶9(MMP-9)在非小细胞肺癌(NSCLC)中的表达,分析其与临床生物学行为的关系。方法应用免疫组化法检测73例NSCLC、51例相应的癌旁组织和13例非肿瘤性肺组织的KAI1和TIMP-1、MMP-9的表达,采用χ2检验和Pearson法分析三者与临床生物学行为的相关性。结果在73例NSCLC和64例癌旁及非肿瘤组织中,KAI1和TIMP-1的阳性率分别为39.7%、74.0%和90.6%、37.5%,两者比较差异有统计学意义(P<0.05),而 MMP-9阳性率为79.4%和67.1%,两者比较差异无统计学意义(P>0.05)。在NSCLC组织中,KAI1检出率在不同TNM分期、淋巴结有无转移、不同肿瘤类型中差异有统计学意义(P<0.05),TIMP-1、MMP-9的检出率在不同TNM分期、淋巴结有无转移中差异有统计学意义(P<0.05),三者检出率与年龄、性别无关;KAI1的表达与TIMP-1、MMP-9呈负相关(r=-0.4637、-0.3445,P<0.05)。结论 KAI1和TIMP-1、MMP-9均与肺癌的发展、转移有关,联合检测三者可成为评价NSCLC发生、发展的预后参考指标。%Objective To investigate the expressions of KAI1 gene,tissue inhibitor 1 of metalloproteinase (TIMP-1)and matrix metalloproteinase 9 (MMP-9)in non-small cell lung cancer (NSCLC)and their correlations with clinicopathologic features of NSCLC.Methods The expressions of KAI1 ,TIMP-1 and MMP-9 in 73 specimens of NSCLC tissues,51 specimens of corresponding adjacent tissues and 13 specimens of non-cancerous lung tissue were determined by immunohistochemistry.Their correlations with clinicopathologic features were analyzed by χ2 test and Pearson analysis.Results In 73 specimens of NSCLC tissues and 64 cases of corresponding adjacent and non-cancerous lung tissues,the positive rates of KAI1 and TIMP-1 were 39.7%,74.0% and 90.6%,37.5% with statistical significance (P 0.05 ).The expression of KAI1 was correlated to TNM stage,lymph node metastasis,histologic subtype and differentiation with statistical significance (P<0.05),and the TIMP-1 and MMP-9 were correlated to TNM stage and lymph node metastasis (P<0.05),but they were not correlated to age and sex.The expression of KAI1 was negatively correlated with the expressions of TIMP-1 and MMP-9 (r=-0.463 7,-0.344 5,P<0.05).Conclusions The KAI1 ,TIMP-1 and MMP-9 are related to the development of lung cancer.The combination determination of them will be the important prognosis reference indicator for the occurrence and development of NSCLS.
    • 刘旭; 郭晓钟; 李宏宇; 陈江; 任丽楠; 吴春燕; 许文达
    • 摘要: Objective To observe the inhibitory effect on lymph node metastasis of pancreatic cancer and lymphangiogenesis in mice by injection of KAll gene within xenograft tumor.Methods Pancreatic cancer cell line MiaPaCa-2 wag used to construct the nude mice models bearing tumors,then the mice were divided into normal saline group,Ad group and Ad-KAI1 group.Since the successful model construction,normal saline,Ad,Ad-KAI1 was injected every week for 3 times,respectively in the three groups,then the tumor size was documented.50 d after model construction,the tumor and enlarged lymph nodes were collected and subjected to pathological exam,and the expression of LYVE-1 and the MLVD in xenograft tumor was detected by immunohistochemistry.Results Two weeks after MiaPaCa-2 implantation,the model was 100% successfully constructed.The growth curve of subcutaneous tumor among 3 groups was not statistically significant (P>0.05) ; the weights of subcutaneous tumor in the 3 groups were (2514.4 ±351.3),(2466.1 ± 295.5),(2294.4±255.4) mg after 50 d,and the difference among the 3 groups was not statistically significant (P >0.05).Enlarged lymph nodes metastasis was observed in 8 mice (80%) in normal saline group,and 20 lymph nodes were collected,with 2.0 lymph nodes per mice; and enlarged lymph nodes metastasis was observed in 7 mice (70%) in Ad group,and 15 lymph nodes were collected,with 1.5 lymph nodes per mice; while enlarged lymph nodes metastasis was observed in 4 mice (40%) in Ad-KAI1 group,and 6 lymph nodes were collected,with 0.6 lymph nodes per mice.All the lymph nodes were confirmed to be metastasis of the primary tumor after pathologic exam.The difference of lymph nodes metastasis,number of lymph nodes metastasis per mice among the 3 groups was statistically significant (F =3.14,3.35,P < 0.05).The MLVD of subcutaneous tumor among the 3 groups was (18.70 ± 5.60),(19.40 ± 4.58),(9.80 ±4.10)/400 times magnification,the MLVD of Ad-KAI1 group was significantly lower than those in normal saline group and Ad group (F10.76,11.36,P < 0.05),but the difference between normal saline group and Ad group was not statistically significant.Conclusions KAI1 can inhibit the lymph node metastasis of pancreatic cancer,and the mechanism may be related with decreased lymphangiogenesis and reduced lymphatic vessel density.%目的 探讨KAI1基因对裸鼠胰腺癌种植瘤淋巴结转移及淋巴管新生的作用.方法 建立裸鼠的人胰腺癌MiaPaCa-2细胞皮下种植瘤模型,成瘤后应用KAI1腺病毒(Ad-KAI1)瘤内注射治疗,每周1次,共3次,以瘤内注射腺病毒(Ad)或生理盐水组作为对照,记录肿瘤生长情况.成瘤50 d收集瘤体及肿大淋巴结,常规病理学检查,并采用免疫组化法检测瘤组织中淋巴管特异性标志物LYVE-1表达,计算微淋巴管密度(MLVD).结果 裸鼠接种MiaPaCa-2细胞2周后100%成瘤.生理盐水组、Ad组、Ad-KAI1组裸鼠种植瘤的生长速度无明显差异(P>0.05);50 d后收集的瘤体重量分别为(2514.4 ±351.3)、(2466.1±295.5)、(2294.4±255.4) mg,组间差异无统计学意义.生理盐水组8只(80%)发现肿大淋巴结转移,共收集到肿大淋巴结20枚,平均2.0枚/只;Ad组7只(70%)发现肿大淋巴结,共收集到肿大淋巴结15枚,平均1.5枚/只;Ad-KAI1组4只(40%)发现肿大淋巴结,共收集到肿大淋巴结6枚,平均0.6枚/只.所有肿大淋巴结均经病理学检查确定为肿瘤的淋巴转移灶.3组裸鼠肿瘤淋巴结转移及每只裸鼠平均淋巴结转移数的差异均有统计学意义(F值分别为3.14、3.35,P值均<0.05).生理盐水组、Ad组、Ad-KAI1组裸鼠胰腺癌种植瘤组织中MLVD分别为(18.70±5.60)、(19.40±4.58)、(9.80±4.10)个/400倍视野,Ad-KAI1组MLVD显著低于生理盐水组和Ad组,差异有统计学意义(F值分别为10.76、11.36,P值均<0.05),而生理盐水组和Ad组间的差异无统计学意义.结论 KAI1可能通过减少裸鼠种植瘤组织中的淋巴管新生、降低微淋巴管密度来抑制胰腺癌的淋巴转移.
    • 段建峰; 刘晓晨; 豆发福; 郑明华; 李光华; 周亚东; 丁建龙; 刘李; 赵喜荣
    • 摘要: 目的:探讨KAI-1基因在胃癌组织中的表达和临床意义,以及与病理类型的联系.方法:选取2008年3月-2011年3月行手术治疗的胃癌患者40例和同期手术治疗的非胃癌疾病患者20例的胃石蜡标本,采用免疫组织化学染色SABC法检测癌组织及胃良性病变组织中的KAI-1基因的表达.结果:KAI-1基因在胃癌组织中的表达阳性率明显低于胃良性病变组织(P<0.05).且这种表达差异体现在不同的胃癌组织类型中.结论:KAI-1基因的低表达可能是导致肿瘤侵袭力增强和易发生转移的危险因素之一.%Objective:To explore the expressions of KAI-1 Gene in Gastric Cancer and Their Pathological Significances.Methods:The forty samples of Gastric Cancer were collected from 2008 to 2011 and 20 cases Gastric samples of non Gastric cancer were collected as control.The expressions of KAI-1 Gene were detected by immunohistochemical strept-avidin-biotin complex(SABC) method.Results:The positive rates of KAI-1 Gene in Gastric Cancer tissues were lower than the Gastric tissues of non Gastric cancer,and the difference were shown the pathological type of Gastric Cancer.Conclusion:The low expression of KAI-1 Gene in Gastric Cancer maybe is one of dangerous factor caused metastasis easily.
    • 刘旭; 郭晓钟; 李宏宇; 陈江; 许文达
    • 摘要: Objective To investigate the effects of KAll gene transfection on proliferation,migration,invasion and VEGF expression of pancreatic cancer MiaPaCa-2 cells under hypoxic condition,and explore possible mechanism.Methods The pcMV-KAI1 vector which contained the full length of KAI1 cDNA was transfected into pancreatic cancer cells MiaPaCa-2,and KAI1,VEGF C,VEGF A protein expressions were determined by Western blot.The proliferation of pancreatic cancer cells was evaluated by MTT method.Wound-healing assay and cell invasion assay were used to detect the migration and invasion of pancreatic cancer cells.The expression of VEGF C,VEGF A in supernatant of culture was measured by ELISA method.Results The expression of KAI1 protein in MiaPaCa-2 K transfected with KAI1 was significantly higher than that in nontransfected cells [(0.549 ± 0.021) vs 0,P<0.05].The proliferation under hypoxic condition was not significantly different,but the migration distance was significantly shorter and the number of transmembrane cell was significantly decreased [(14.0 ± 5.8) vs (43.0 ± 14.4),P < 0.05].The expression of VEGF-C in cell was significantly decreased [(0.218 ± 0.043) vs (0.745 ± 0.069),P <0.05],but the expression of VEGF-A was not significantly different; the expression of VEGF-C in cell culture supernatants was significantly decreased [(1236 ± 247) vs (2045 ± 221) pg/ml,P < 0.01].Conclusions The migration,invasion ability of pancreatic cancer MiaPaCa-2 cells with KAll transfection under hypoxic condition is decreased,and the possible mechanism of inhibiting lymphatic metastasis is down-regulation of VEGF-C expression.%目的 观察转染KAI1基因的人胰腺癌MiaPaCa-2细胞在乏氧条件下培养后细胞增殖、迁移、侵袭能力的变化,探讨其可能机制.方法 应用KAl1基因过表达质粒转染乏氧条件培养后的人胰腺癌MiaPaCa-2细胞,采用蛋白质印迹法检测转染细胞KAI1、VEGF-C、VEGF-A蛋白的表达,四甲基偶氮唑蓝(MTT)法检测转染细胞的增殖,细胞划痕及Transwell小室实验观察转染细胞的迁移及侵袭能力,酶联免疫吸附测定法检测培养上清液中人VEGF-C、VEGF-A含量.结果 转染KAI1基因后的MiaPaCa-2-K细胞的KAI1蛋白表达量较未转染细胞显著增加[(0.549 ±0.021)比0].乏氧条件培养后转染细胞的增殖无明显变化,但它的迁移距离明显缩短,穿膜细胞数显著减少[(14.0±5.8)比(43.0±14.4)个,P<0.05];细胞的VEGF-C表达显著降低[(0.218±0.043)比(0.745±0.069).P<0.05],但VEGF-A表达变化不显著;细胞培养上清液中VEGF-C含量显著减少[(1236±247)比(2045±221) pg/ml,P<0.01].结论 转染KAl1基因的MiaPaCa-2细胞在乏氧条件下培养后的细胞迁移、侵袭能力减弱,其机制可能是通过下调VEGF-C的表达来抑制胰腺癌淋巴转移的.
    • 周荣平; 陈刚; 程顺舟; 沈志力; 陆小伟
    • 摘要: 目的:探讨Kai-1基因的缺失与突变在胃癌演进与转移中的意义.方法:提取30例胃癌患者的肿瘤组织(16例无淋巴转移,14例有淋巴转移),30例癌旁正常组织的RNA,RT-PCR扩增,电泳检测,测序验证Kai-1基因的缺失情况;并提取发生缺失的肿瘤组织的DNA,PCR扩增,测序探讨Kai-1基因的突变情况.结果:30例组织标本中12例出现Kai-1基因exon9缺失(10例杂合缺失,2例纯合缺失),30例癌旁正常组织中有5例出现Kai-1基因exon9缺失(5例杂合缺失);在胃癌组织中Kai-1基因缺失频率显著高于在癌旁正常组织(P0.05).结论:Kai-1基因缺失与突变可能与胃癌演进、转移有关,检测其缺失或突变可作为判断胃癌的演进与转移的客观临床指标.
    • 徐洪波; 江浩
    • 摘要: @@ KAI-1基因是1995年美国国立环境健康研究院Dong等[1]采用人特异的Alu元素-PCR方法,从人前列腺癌中发现的肿瘤转移抑制基因,最初只被认为是前列腺癌转移的特异性抑制因子,但随后的研究者们应用RT-PCR、原位杂交及免疫组织化学等方法,发现其他恶性肿瘤也存在KAI-1基因失活[2].本文对KAI-1基因及其编码产物的结构、功能、抑制肿瘤转移的可能机制及其与各种肿瘤的关系作一综述.
    • 马大伟; 吴剑秋
    • 摘要: 目的 探讨KAI1基因的异常剪接与乳腺癌进展、转移的关系.方法 提取48例乳腺癌组织的RNA,利用RT-PCR技术进行逆转录扩增KAI1基因,电泳检测KAI1基因的异常剪接,测序验证,统计分析KAI1基因的异常剪接与乳腺癌进展、转移的关系.结果 48例乳腺癌组织中,20例(42%)出现KAI1基因异常剪接,导致第9外显子(exon9)杂合性缺失;有淋巴结转移的乳腺癌组织中,基因异常剪接导致exon9表达缺失的频率明显高于无淋巴结转移者(P0.05).结论 KAI1基因的异常剪接可能与乳腺癌的进展、转移有关,异常剪接的检测可作为预测肿瘤进展、转移的临床指标.
    • 徐小杰; 梅同华
    • 摘要: 目的 探讨KAI1基因表达与非小细胞肺癌(NSCLC)转移预后的关系.方法 采用SP免疫组织化学方法检测62例NSCLC原发灶及22例淋巴结转移灶中KAI1基因的表达.结果 KAI1基因在NSCLC组织中阳性表达率32.26%,癌旁正常肺组织为85.0%,两者差异有统计学意义(p<0.01).KAI1基因在低分化、TNM分期Ⅲ~Ⅳ期及有淋巴结转移肿瘤中表达显著降低(P<0.05).淋巴结转移灶的KAI1基因表达水平显著低于原发灶(P<0.05).KAI1基因表达阳性的患者3年生存率明显高于阴性者(P<0.05).通过Cox回归分析发现KAI1/CD82表达及有无淋巴结转移可作为独立的因素影响非小细胞肺癌患者术后的3年生存率.结论 KAI1低表达可能与NSCLC的恶性进展有关,可作为判断NSCLC早期侵袭、转移及预后的重要指标之一;同时对指导治疗方案的选择提供了分子生物学的参考依据.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号